Dr Richard Hoglund
Contact information
Research groups
Richard Hoglund
Head of Pharmacometrics
Clinical Pharmacology
Richard Hoglund heads the pharmacometrics group at the department of Clinical Pharmacology, MORU. He has a background in chemical engineering and pharmacology and his research is mainly focused on pharmacometrics, pharmacokinetics, pharmacodynamics and mathematical modelling in tropical medicine research, with a particular focus on antimalarial therapy.
More specific, his main research aims to optimise current and future antimalarial therapies by utilizing pharmacometric methodologies. A pharmacometric modelling approach can identify specific groups at risk of treatment failure and the derived pharmacometric models can help to evaluate and suggest new dose regimens to improve the treatment of malaria.
Recent publications
-
Pharmacometric and statistical considerations for dose optimization
Chotsiri P. et al, (2024), CPT: Pharmacometrics & Systems Pharmacology
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
Wattanakul T. et al, (2024), Nature Communications, 15
-
Medication adherence framework: A population‐based pharmacokinetic approach and its application in antimalarial treatment assessments
Ding J. et al, (2024), CPT: Pharmacometrics & Systems Pharmacology, 13, 795 - 811
-
Efficacy of ultra-short, response-guided sofosbuvir and daclatasvir therapy for hepatitis C in a single-arm mechanistic pilot study
Flower B. et al, (2023), eLife, 12
-
Pharmacometric and Electrocardiographic Evaluation of Chloroquine and Azithromycin in Healthy Volunteers
Chotsiri P. et al, (2022), Clinical Pharmacology & Therapeutics, 112, 824 - 835